as on
| Source : NSE
as on August 22, 2025 at 4:01 PM IST
Day's Low
Day's High
1.01%
Downside
1.32%
Upside
52 Week's Low
52 Week's High
9.36%
Downside
77.91%
Upside
Market Stats | |
Previous Close | ₹548.25 |
Open | ₹549.00 |
Volume | 28.21K |
Upper Circuit | ₹657.90 |
Lower Circuit | ₹438.60 |
Day's Low | ₹545 |
Day's High | ₹557.8 |
52 Week Low | ₹499 |
52 Week High | ₹979.5 |
Returns % | |
1 Month Return | -1.23 % |
3 Month Return | -0.28 % |
1 Year Return | -23.84 % |
3 Year Return | + 95.04 % |
5 Year Return | + 122.82 % |
Check Lincoln Pharmaceuticals Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
₹1,098.13 Cr
Return on Equity (ROE)
17.04
PE Ratio (TTM)
12.71
Return on capital employed (ROCE)
22.35
Industry PE ratio
43.37
Beta (LTM)
1.12
P/B Ratio
1.98
Dividend Yield
0.31
PEG Ratio
-2.2
Quarterly Earnings Growth YOY
16.94
EPS (TTM)
46.58
Sector
Pharmaceuticals
Book Value
295.98
Technical Analysis
Bearish
View Technical Analysis
Track how Lincoln Pharmaceuticals Ltd P/E has moved over time to understand its valuation trends.
Lincoln Pharmaceuticals Ltd in the last 5 years
Lowest (3.58x)
March 23, 2020
Today (12.71x)
August 21, 2025
Industry (43.37x)
August 21, 2025
Highest (19.77x)
December 9, 2024
Today’s Price to Earnings Ratio: 12.71x
Get the annual and quarterly financial summary of Lincoln Pharmaceuticals Ltd, including revenue, profit, loss and more.
View detailed summary of the earnings and dividend history of Lincoln Pharmaceuticals Ltd.
Lincoln Pharmaceuticals Ltd’s net profit jumped 16.94% since last year same period to ₹27.68Cr in the Q1 2025-2026. On a quarterly growth basis, Lincoln Pharmaceuticals Ltd has generated 139.03% jump in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2024, Lincoln Pharmaceuticals Ltd has declared dividend of ₹1.80 per share on 16 May 2024 - translating a dividend yield of 0.60%.
Read More about DividendsCheck stock indices that include Lincoln Pharmaceuticals Ltd.
View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Lincoln Pharmaceuticals Ltd.
Investors | Holdings % | Quarterly Trend | 3M change |
---|---|---|---|
Promoter Holdings | 49.78% | 0.00 | |
Foreign Institutions | 5.14% | 2.86 | |
Mutual Funds | 0% | 5.88 | |
Retail Investors | 45.07% | ||
Others | 0.01% | 106.82 |
Compare market cap, revenue, PE, and other key metrics of Lincoln Pharmaceuticals Ltd with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
---|---|---|---|---|---|---|
NA | 1,098.13 | 24.56% | 0.50 | 93 | 580 | |
NA | 144.70 | 17.83% | 0.84 | 7 | 339 | |
NA | 509.12 | 22.09% | 0.00 | NA | NA | |
NA | 732.08 | 31.15% | 0.51 | 421 | 1,280 | |
NA | 6.03 | -7.89% | 0.00 | -6 | NA |
Latest news and events in one place to help you make informed investing decisions in Lincoln Pharmaceuticals Ltd.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Profit Spike
Netprofit is up for the last 2 quarters, 11.58 Cr → 27.68 Cr (in ₹), with an average increase of 58.2% per quarter
FII Holding Up
Foreign Institutions have increased holdings from 5.00% to 5.14% in Jun 2025 quarter
Revenue Rich
Revenue is up for the last 3 quarters, 155.52 Cr → 169.34 Cr (in ₹), with an average increase of 4.2% per quarter
Against Peers
In the last 3 years, Torrent Pharmaceuticals Ltd has given 138.9% return, outperforming this stock by 43.9%
Promoter Holding Unchanged
Promoters holdings remained unchanged at 49.78% of holdings in Jun 2025 quarter
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 22.7% return, outperforming this stock by 46.6%
Price Dip
In the last 6 months, LINCOLN stock has moved down by -2.4%
Retail Holding Down
Retail Investor have decreased holdings from 45.22% to 45.07% in Jun 2025 quarter
Organisation | Lincoln Pharmaceuticals Ltd |
Headquarters | Ahmedabad |
Industry | Pharmaceuticals |
CEO | Kishorbhai M Shah |
E-voting on shares | Click here to vote |
Check out the Mutual Funds with significant holdings in Lincoln Pharmaceuticals Ltd.
Funds | Holdings | Prev. 5M |
---|---|---|
Bandhan BSE Healthcare Index Fund Direct Growth | 0.04% |
Lincoln Pharmaceuticals Ltd share price today stands at ₹550.55, Open: ₹549, Previous Close: ₹548.25, High: ₹557.8, Low: ₹545, 52 Week High: ₹979.5, 52 Week Low: ₹499 as on .
To buy Lincoln Pharmaceuticals Ltd shares, you need to follow these steps:
Today's traded volume of Lincoln Pharmaceuticals Ltd is 28.21K. Which means that 28.21K shares of Lincoln Pharmaceuticals Ltd were bought and sold on the stock market during today's trading session.
Today's market capitalisation of Lincoln Pharmaceuticals Ltd is ₹1,098.13 Cr. Market cap or market capitalisation is the total value of a company’s outstanding shares in the stock market, calculated by multiplying the current share price by the total number of shares issued by the company.
Lincoln Pharmaceuticals Ltd’s 52 week high is ₹979.5 and 52 week low is ₹499. The current share price of Lincoln Pharmaceuticals Ltd is ₹550.55, which is -43.79% down from its 52 week high and 10.33% up from its 52 week low.